CARLSMED, INC. (CARL) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-03-04

Key Insights

Insider Michael Cordonnier, the CEO and President of Carlsmed, Inc., engaged in significant stock transactions including exercising stock options and selling shares to cover costs, indicating potential confidence in the company's future prospects.
The transactions occurred over a two-day period, suggesting a planned and strategic approach to managing Cordonnier's equity holdings in the company.
Cordonnier continues to hold a sizable stake in Carlsmed, Inc., with over 1.5 million shares beneficially owned after the reported transactions, aligning his interests with those of other shareholders.

Want the newest filings?

This analysis covers the filing from 2026-03-04. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-01-30

Leonard M. Greenstein, the CFO and Treasurer of Carlsmed, Inc., acquired 44,977 shares of the company's common stock through restricted stock units (RSUs) that will vest over three years.
This insider purchase indicates Greenstein's confidence in the company's future and aligns his interests with those of shareholders.
The vesting schedule of the RSUs suggests a long-term investment perspective, as the shares will not be fully owned by Greenstein for several years.

Filed: 2026-01-30

Michael Cordonnier, the CEO and President of Carlsmed, Inc., acquired 117,316 shares of the company's common stock on January 28, 2026. This represents a direct increase in his ownership stake in the company.
The restricted stock units (RSUs) granted to Cordonnier will vest in three equal annual installments, aligning his incentives with long-term shareholder value creation.
As a director and executive officer, Cordonnier's transaction provides a positive signal about his confidence in the company's future prospects.

Filed: 2026-01-30

Niall Casey, the Chief IP Officer, acquired 44,977 shares of CARLSMED, INC. (CARL) common stock on January 28, 2026, increasing his direct beneficial ownership to 982,562 shares.
The shares acquired were in the form of restricted stock units (RSUs) that will vest in three equal annual installments starting from the first anniversary of the grant date.
The insider buying activity suggests that Niall Casey, a key executive, is confident in the company's future prospects and is aligning his interests with those of shareholders.

Filed: 2026-01-30

The reporting person, William Scott Durall, acquired 44,977 shares of CARLSMED, INC. (CARL) common stock, indicating an increase in his beneficial ownership of the company.
The shares were acquired as restricted stock units (RSUs) that will vest in three equal annual installments, aligning the reporting person's interests with long-term company performance.
This transaction suggests the reporting person, who holds the position of Chief Commercial Officer, has confidence in the company's future prospects and is willing to increase his stake in the business.

Other reports for CARLSMED, INC.

Current Report Quarterly Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.